Vimarsana
Biggest News Aggregation in the World

Page 34 - Full Year News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Full Year. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Full Year Today - Breaking & Trending Today

Cannabis Company Clever Leaves Reports Q4 And 2023 Results: Revenue Growth And Expense Reductions - Clever Leaves Holdings (NASDAQ:CLVRW), Clever Leaves Holdings (NASDAQ:CLVR) - Vimarsana News

Cannabis Company Clever Leaves Reports Q4 And 2023 Results: Revenue Growth And Expense Reductions - Clever Leaves Holdings (NASDAQ:CLVRW), Clever Leaves Holdings (NASDAQ:CLVR)

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) reported its financial results late Monday for the fourth quarter and full year concluded on December 31, 2023. 

Decisionpoint Systems, Inc. (AMEX:DPSI) Q4 2023 Earnings Call Transcript - Vimarsana News

Decisionpoint Systems, Inc. (AMEX:DPSI) Q4 2023 Earnings Call Transcript

Decisionpoint Systems, Inc. misses on earnings expectations. Reported EPS is $-36.1305 EPS, expectations were $0.06.

The Best ASX Dividend Stocks to Buy - Vimarsana News

The Best ASX Dividend Stocks to Buy

Looking to invest in Dividend Stocks? We explore the best ASX dividend stocks on the Australian Market.

Townsquare Announces Repurchase Of Just Under 10% Of Outstanding Shares - Vimarsana News

Townsquare Announces Repurchase Of Just Under 10% Of Outstanding Shares

Reaffirms Q1'24 And FY'24 Guidance Purchase, NY - Townsquare Media, Inc. announced that today we are repurchasing and retiring 1.5 million shares of Class A common stock held by MSG National...

Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results

MALVERN, Pa., April 02, 2024 -- Annovis Bio, Inc. , a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, today provided a summary of corporate updates...